Twitter Beğeni Hilesi

A 67-year-old man has become the first person in the UK to try what doctors hope will be a revolutionary new treatment for #LungCancer - a vaccine that tells the body how to fight and kill the disease. 💉 🔗 bbc.in/3SXDFog

Discover the latest breakthroughs in #pulmonary research! 💡 Check out Pulmonary Cell News, an online publication and bi-weekly email newsletter by STEMCELL Technologies covering the latest research into lung cancer and pulmonary cells. bit.ly/4aeqW6u

The European Respiratory Society provides a statement reviewing the literature and current practice concerning transition of care in Childhood #InterstitiaLungDiseases, including of the lack of harmonization between adult and child classifications. 🧒 🧑 bit.ly/476NQg6

Researchers in Liheng Cai’s lab may have found an easier way to manage respiratory illnesses like asthma and pulmonary fibrosis via a drug-carrying molecule designed to cure disease by slipping past the lung’s natural defenses. Liheng Cai ACS Nano at.virginia.edu/0yn19v

Scientists uncover intricate cell communication interactions within the tumor microenvironment, identifying 3 lung adenocarcinoma patient subtypes with distinct prognosis, clinical characteristics, mutation status, expression patterns, and more. bit.ly/3T7qtgm

🖥️ A Universität zu Köln team, including Drs. Kludt and Yuan-Wang, develop a clinically useful computational pathology platform for NSCLC that can be a foundation for multiple downstream applications and improve patient care optimization. bit.ly/3yVgvYJ

Happy to share our work examining lung T cell responses during severe pneumonia—including #COVID19: nature.com/articles/s4159…. Huge lift 💪 from The NU SCRIPT Investigators NM Pulmonary and Thoracic Surgery Northwestern Feinberg School of Medicine. Kudos to Nikolay Markov @[email protected] Ziyou Ren & Karolina Senkow 🧵

🍷 Goblet cells from patients with #asthma showed lower expression of genes involved in the interferon response, including OASL, ICAM1, and TNFAIP3, reports a @UnivGroningen team, including Dr. Aurore Gay. bit.ly/4dwEY5K

Small cell lung cancer profiling: Drs. Esther Redin, Alvaro Quintanal-Villalonga, and Charles Rudin at Memorial Sloan Kettering Cancer Center present an updated synthesis of subtypes, vulnerabilities, and plasticity, with an eye towards clinical implications. bit.ly/3XnDPrp

Generate a complete list of materials for your #pulmonary workflow using this Interactive Product Finder from STEMCELL Technologies. Find the right media to culture your cells as monolayers, #organoids, or at the ALI by selecting your preferred cell types and culture format. 🔎

In a Phase III clinical study, researchers report that the addition of pembrolizumab to chemotherapy in patients with TKI-resistant, EGFR-mutant, metastatic nonsquamous NSCLC did not significantly prolong survival compared to placebo. bit.ly/3X94O8X

120 hub genes related to programmed cell death were identified, and an intersection of these 🧬 genes with DEGs yielded 10 key genes, which were enriched in #apoptosis-related pathways. 📖 Heliyon | bit.ly/4edbppT

🦠 Tumor-associated #macrophages are recognized as pivotal contributors to #tumorigenesis. This study aims to uncover the impact of lncRNA NORAD in EVs derived from M2 macrophages in #NSCLC cell lines and xenograft mouse models of NSCLC. 🔗 go.nature.com/3MzrYjX

Scientists demonstrated the 💉 therapeutic efficacy for lung #fibrosis of adult lung cell transplantation using a single-cell suspension of the entire lung in two distinct 🐭 mouse systems. Science Advances | bit.ly/4eeCTeJ

📊 Functional assays in #NSCLC cell lines validated the biological capabilities of SIRT1 on malignant phenotypes, and its impact on #tumorigenicity was further evaluated in vivo. Scientific Reports | 👓 go.nature.com/3XAfe2Z

Yiling is one of our travel award winners. Her research is looking at Navitoclax inhibits senescence in human alveolar type 2 cells from COPD patients. #ERSCongress

Mild versus severe #COVID19 — what's the difference? A new study featuring #StanDOM's Catherine Blish (BlishLab) flags unexpected lung cells as a possible cause. stan.md/3ThA6JJ

🔁 Dr. Jiazhen Wang and team identify a positive feedback loop formed between adipose triglyceride lipase-mediated lipolysis and overexpression of CD36 specific to lung epithelial cells, contributing to #COPD disease progression. bit.ly/4dVeg6T

Targeting ALK receptors in #NSCLC: What's the road ahead? 🛣️ Moscati Hospital authors provide perspective on the future development of ALK inhibitors and management of acquired resistance to first-line treatments. bit.ly/4ehpAdr